Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The Lkb1 metabolic sensor maintains haematopoietic stem cell survival

An Erratum to this article was published on 06 July 2011

This article has been updated


Haematopoietic stem cells (HSCs) can convert between growth states that have marked differences in bioenergetic needs. Although often quiescent in adults, these cells become proliferative upon physiological demand. Balancing HSC energetics in response to nutrient availability and growth state is poorly understood, yet essential for the dynamism of the haematopoietic system. Here we show that the Lkb1 tumour suppressor is critical for the maintenance of energy homeostasis in haematopoietic cells. Lkb1 inactivation in adult mice causes loss of HSC quiescence followed by rapid depletion of all haematopoietic subpopulations. Lkb1-deficient bone marrow cells exhibit mitochondrial defects, alterations in lipid and nucleotide metabolism, and depletion of cellular ATP. The haematopoietic effects are largely independent of Lkb1 regulation of AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling. Instead, these data define a central role for Lkb1 in restricting HSC entry into cell cycle and in broadly maintaining energy homeostasis in haematopoietic cells through a novel metabolic checkpoint.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Figure 1: Lkb1 is required for haematopoiesis.
Figure 2: Cell-autonomous role of Lkb1 in haematopoiesis.
Figure 3: Impact of Lkb1 inactivation on proliferation and apoptosis.
Figure 4: mTORC1 inhibition and AMPK activation do not rescue bone marrow failure in Lkb1 mutants.
Figure 5: Inactivation of Lkb1 alters mitochondrial function of bone marrow cells.

Change history

  • 06 July 2011

    Figs 1 and 2 have been corrected in the original online HTML and PDF versions as described in the accompanying Erratum.


  1. Tothova, Z. & Gilliland, D. G. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. Cell Stem Cell 1, 140–152 (2007)

    Article  CAS  Google Scholar 

  2. Gan, B. et al. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc. Natl Acad. Sci. USA 105, 19384–19389 (2008)

    Article  ADS  CAS  Google Scholar 

  3. Ito, K. et al. Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes. J. Immunol. 178, 103–110 (2007)

    Article  CAS  Google Scholar 

  4. Liu, J. et al. Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 459, 387–392 (2009)

    Article  ADS  CAS  Google Scholar 

  5. Chen, C. et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 205, 2397–2408 (2008)

    Article  CAS  Google Scholar 

  6. Shackelford, D. B. & Shaw, R. J. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nature Rev. Cancer 9, 563–575 (2009)

    Article  CAS  Google Scholar 

  7. Shaw, R. J. et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl Acad. Sci. USA 101, 3329–3335 (2004)

    Article  ADS  CAS  Google Scholar 

  8. Hawley, S. A. et al. Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28 (2003)

    Article  Google Scholar 

  9. Hardie, D. G. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nature Rev. Mol. Cell Biol. 8, 774–785 (2007)

    Article  CAS  Google Scholar 

  10. Narbonne, P. & Roy, R. Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival. Nature 457, 210–214 (2009)

    Article  ADS  CAS  Google Scholar 

  11. Lizcano, J. M. et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK//PAR-1. EMBO J. 23, 833–843 (2004)

    Article  CAS  Google Scholar 

  12. Kiel, M. J. et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109–1121 (2005)

    Article  CAS  Google Scholar 

  13. Bardeesy, N. et al. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419, 162–167 (2002)

    Article  ADS  CAS  Google Scholar 

  14. Kuhn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427–1429 (1995)

    Article  ADS  CAS  Google Scholar 

  15. Chan, I. T. et al. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J. Clin. Invest. 113, 528–538 (2004)

    Article  CAS  Google Scholar 

  16. Torchia, E. C., Boyd, K., Rehg, J. E., Qu, C. & Baker, S. J. EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice. Mol. Cell. Biol. 27, 7918–7934 (2007)

    Article  CAS  Google Scholar 

  17. Essers, M. A. G. et al. IFNα activates dormant haematopoietic stem cells in vivo . Nature 458, 904–908 (2009)

    Article  ADS  CAS  Google Scholar 

  18. Maiuri, M. C., Zalckvar, E., Kimchi, A. & Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nature Rev. Mol. Cell Biol. 8, 741–752 (2007)

    Article  CAS  Google Scholar 

  19. Ichimura, Y. et al. A ubiquitin-like system mediates protein lipidation. Nature 408, 488–492 (2000)

    Article  ADS  CAS  Google Scholar 

  20. Shaw, R. J. et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6, 91–99 (2004)

    Article  CAS  Google Scholar 

  21. Corradetti, M. N., Inoki, K., Bardeesy, N., DePinho, R. A. & Guan, K. L. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev. 18, 1533–1538 (2004)

    Article  CAS  Google Scholar 

  22. Shaw, R. J. et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642–1646 (2005)

    Article  ADS  CAS  Google Scholar 

  23. Koh, H. J. et al. Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol. Cell. Biol. 26, 8217–8227 (2006)

    Article  CAS  Google Scholar 

  24. Koh, H. J. et al. Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle. Proc. Natl Acad. Sci. USA 10.1073/pnas.1008131107 (16 August 2010)

  25. Gurumurthy, S. et al. LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis. Cancer Res. 68, 55–63 (2008)

    Article  CAS  Google Scholar 

  26. Contreras, C. M. et al. Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas. Cancer Res. 68, 759–766 (2008)

    Article  CAS  Google Scholar 

  27. Hezel, A. F. et al. Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol. Cell. Biol. 28, 2414–2425 (2008)

    Article  CAS  Google Scholar 

  28. Sanchez-Cespedes, M. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26, 7825–7832 (2007)

    Article  CAS  Google Scholar 

  29. Klimova, T. A. et al. Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS. FASEB J. 23, 783–794 (2009)

    Article  CAS  Google Scholar 

  30. Ozsolak, F. et al. Direct RNA sequencing. Nature 461, 814–818 (2009)

    Article  ADS  CAS  Google Scholar 

  31. Hezel, A. F. & Bardeesy, N. LKB1; linking cell structure and tumor suppression. Oncogene 27, 6908–6919 (2008)

    Article  CAS  Google Scholar 

  32. Nakada, D., Saunders, T. L. & Morrison, S. J. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 10.1038/nature09571 (this issue)

  33. Gan, B. et al. Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 10.1038/nature09595 (this issue)

  34. Watson, M. et al. The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Mol. Cell. Biol. 29, 5872–5888 (2009)

    Article  CAS  Google Scholar 

  35. Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo . Nature 445, 661–665 (2007)

    Article  CAS  Google Scholar 

  36. Ferrick, D. A., Neilson, A. & Beeson, C. Advances in measuring cellular bioenergetics using extracellular flux. Drug Discov. Today 13, 268–274 (2008)

    Article  CAS  Google Scholar 

  37. Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010)

    Article  Google Scholar 

Download references


We would like to thank the Harvard Stem Cell Institute Flow Cytometry Core and D. Brown and the MGH Electron Microscope Imaging Core for expertise and advice. V. Levy and M. Leisa provided technical assistance in the SeaHorse measurements. D. Van Buren provided advice and assistance in pilot experiments. We thank A. Camacho for mouse colony assistance. We would also like to thank A. Kimmelman, R. Mostoslavsky, M. Vander Heiden, L. Ellisen, W. Kim and M. Ivan for discussions and critical review of the manuscript. We are grateful to S. Morrison and R. DePinho for sharing unpublished data. N.B. would like to acknowledge support from NIH U01 CA141576-01. D.T.S would like to acknowledge support from NIH DK050234 and Ellison Medical Foundation. S.G. was supported by a Massachusetts Biotechnology Research Council Tosteson Fellowship. S.Z.X. was supported by an NIH Ruth L. Kirschstein National Research Service Award.

Author information

Authors and Affiliations



S.G. and S.Z.X. performed the experiments with assistance from B.A., J.K., A.T., B.S. and R.Z.Y. S.G., S.Z.X., D.T.S. and N.B. designed the experiments, analysed and evaluated all data, and wrote the manuscript. F.O. and P.M. performed the RNA sequencing. F.F. and P.J.P. analysed the RNA sequencing data. O.S.S. designed and evaluated the oxygen consumption experiments.

Corresponding authors

Correspondence to David T. Scadden or Nabeel Bardeesy.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-11 with legends. (PDF 745 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gurumurthy, S., Xie, S., Alagesan, B. et al. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468, 659–663 (2010).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing